These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 33239100)

  • 41. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol.
    Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C; Benhalima K
    BMC Pregnancy Childbirth; 2023 Mar; 23(1):180. PubMed ID: 36927458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing - a randomised controlled trial.
    Olsen MT; Klarskov CK; Pedersen-Bjergaard U; Hansen KB; Kristensen PL
    BMC Endocr Disord; 2024 May; 24(1):60. PubMed ID: 38711112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of continuous glucose monitoring in patients with type 1 diabetes at two district hospitals in Neno, Malawi: a randomised controlled trial.
    Gomber A; Valeta F; Coates MM; Trujillo C; Ferrari G; Boti M; Kumwenda K; Mailosi B; Nakotwa D; Drown L; Wroe EB; Thapa A; Mithi V; Matanje B; Msekandiana A; Park PH; Kachimanga C; Bukhman G; Ruderman T; Adler AJ
    BMJ Open; 2024 May; 14(5):e075554. PubMed ID: 38719319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of a culturally tailored diabetes education curriculum with real-time continuous glucose monitoring in a Latinx population with type 2 diabetes: the CUT-DM with CGM for Latinx randomised controlled trial study protocol.
    Ehrhardt N; Cedeno B; Montour L; Sinclair K; Ferguson G; Berberian P; Comstock B; Wright L
    BMJ Open; 2023 Dec; 13(12):e082005. PubMed ID: 38154895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overcoming Clinical Inertia: A Randomized Clinical Trial of a Telehealth Remote Monitoring Intervention Using Paired Glucose Testing in Adults With Type 2 Diabetes.
    Greenwood DA; Blozis SA; Young HM; Nesbitt TS; Quinn CC
    J Med Internet Res; 2015 Jul; 17(7):e178. PubMed ID: 26199142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.
    Lind N; Christensen MB; Hansen DL; Nørgaard K
    Diabetes Care; 2024 May; 47(5):881-889. PubMed ID: 38489032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-time continuous glucose monitoring versus self-monitoring of blood glucose in adults with insulin-treated type 2 diabetes: a protocol for a randomised controlled single-centre trial.
    Lind N; Lindqvist Hansen D; Sætre Rasmussen S; Nørgaard K
    BMJ Open; 2021 Jan; 11(1):e040648. PubMed ID: 33452188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trial.
    Sehgal S; De Bock M; Williman J; Taylor B; Elbalshy M; Galland B; Hall R; Paul R; Boucsein A; Jones S; Frewen C; Wheeler BJ
    J Diabetes Metab Disord; 2021 Dec; 20(2):2103-2113. PubMed ID: 34900846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
    Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
    Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
    Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
    Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial.
    Beardsall K; Thomson L; Guy C; Iglesias-Platas I; van Weissenbruch MM; Bond S; Allison A; Kim S; Petrou S; Pantaleo B; Hovorka R; Dunger D;
    Lancet Child Adolesc Health; 2021 Apr; 5(4):265-273. PubMed ID: 33577770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].
    Polonsky W; Fisher L; Schikman C; Hinnen D; Parkin C; Jelsovsky Z; Amstutz L; Schweitzer M; Wagner R
    BMC Fam Pract; 2010 May; 11():37. PubMed ID: 20482765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial.
    Idrees T; Castro-Revoredo IA; Oh HD; Gavaller MD; Zabala Z; Moreno E; Moazzami B; Galindo RJ; Vellanki P; Cabb E; Johnson TM; Peng L; Umpierrez GE
    J Am Med Dir Assoc; 2024 May; 25(5):884-888. PubMed ID: 38460943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Diabetes teleMonitoring of patients in insulin Therapy (DiaMonT) trial: study protocol for a randomized controlled trial.
    Hangaard S; Kronborg T; Hejlesen O; Aradóttir TB; Kaas A; Bengtsson H; Vestergaard P; Jensen MH
    Trials; 2022 Dec; 23(1):985. PubMed ID: 36476605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.